Comparison of immediate versus day to day variability of ventricular tachycardia induction by programmed stimulation

Journal of the American College of Cardiology

Volumn 13, Issue 7, 1989, Pages 1599-1607

  Cooper, Mark J ^a   Choong Koo, Chee ^a   Skinner, Michael P ^a   Mortensen, Peter T ^a   Hunt, Lesley J ^a   Richards, David A ^a   Uther, John B ^a   Ross, David L ^a  

^a WESTMEAD HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; CLINICAL ARTICLE; ELECTROSTIMULATION; HEART ELECTROPHYSIOLOGY; HEART VENTRICLE TACHYCARDIA; HUMAN; METHODOLOGY; PRIORITY JOURNAL;

ADULT; AGED; ANTI-ARRHYTHMIA AGENTS; CARDIAC PACING, ARTIFICIAL; COMPARATIVE STUDY; ELECTROCARDIOGRAPHY; ELECTROPHYSIOLOGY; FEMALE; HEART CONDUCTION SYSTEM; HUMAN; MALE; MIDDLE AGE; PROSPECTIVE STUDIES; SUPPORT, NON-U.S. GOV'T; TACHYCARDIA;

EID: 0024393047     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/0735-1097(89)90354-9     Document Type: Article

References (29)

1. Day-to-day reproducibility of responses to right ventricular programmed electrical stimulation: implications for serial drug testing
2. Daily reproducibility of electrophysiologic test results in malignant ventricular arrhythmia
3. Quantitation of day to day variability in mode of induction of ventricular tachyarrhythmias by programmed stimulation
4. Out-of-hospital cardiac arrest: electrophysiologic observations and selection of long-term antiarrhythmic therapy
5. Selection of optimal drug treatment of ventricular tachycardia by programmed electrical stimulation of the heart
6. Antiarrhythmic drug efficacy for ventricular tachyarrhythmias associated with coronary artery disease as assessed by electrophysiologic studies
7. Prognostic value of the changes in the mode of ventricular tachycardia induction during therapy with amiodarone or amiodarone and a class IA antiarrhythmic agent
8. Cardiac pacing and pacemakers. II. Serial electrophysiologic-pharmacologic testing for control of recurrent tachyarrhythmias
9. Electrode-catheter arrhythmia induction in the selection and assessment of antiarrhythmic drug therapy for recurrent ventricular tachycardia
10. Recurrent sustained ventricular tachycardia. 3. Role of the electrophysiologic study in selection of antiarrhythmic regimens
11. Effect of repetition of extrastimuli on sensitivity and reproducibility of mode of induction of ventricular tachycardia by programmed stimulation
12. Determinants of survival in patients with ventricular tachyarrhythmias
13. A randomized clinical trial of the noninvasive and invasive approaches to drug therapy of ventricular tachycardia
14. Out-of-hospital cardiac arrest: use of electrophysiologic testing in the prediction of long-term outcome
15. Reduction in sudden death and total mortality by antiarrhythmic therapy evaluated by electrophysiologic drug testing: criteria of efficacy in patients with sustained ventricular tachyarrhythmia
16. Flecainide its proarrhythmic effect and expected changes on the surface electrocardiogram
17. Immediate reproducibility of clinical and nonclinical forms of induced ventricular tachycardia
18. Reproducibility of arrhythmia induction with intracardiac electrophysiologic testing: patients with clinical sustained ventricular tachyarrhythmias
19. Sensitivity, specificity and reproducibility of programmed ventricular stimulation
20. Decreased incidence of antiarrhythmic drug efficacy at electrophysiologic study associated with the use of a third extrastimulus
21. Prediction of proarrhythmic drug effects at electrophysiologic study for ventricular tachycardia (abstr)
22. Antiarrhythmic drugs retard rather than suppress induction of ventricular tachycardia (abstr)
23. The plasma catecholamine response to ventricular tachycardia induction and external countershock during electrophysiologic testing
24. A comparison of the electrophysiologic effects of intravenous and oral amiodarone in the same patient
25. Acute and chronic effects of amiodarone on ventricular refractoriness, intraventricular conduction and ventricular tachycardia induction
26. Encainide and its metabolites: comparative effects in man on ventricular arrhythmias and electrocardiographic intervals
27. Is programmed stimulation of value in predicting the long-term success of antiarrhythmic therapy for ventricular tachycardias?
28. Mechanism of prevention of sudden death by nadolol: differential actions on arrhythmia triggers and substrate after myocardial infarction in the dog